Latest News in the pharma Industry

Top Stories

AstraZeneca to Acquire Ardea Biosciences And Lead Product Lesinurad

AstraZeneca to Acquire Ardea Biosciences And Lead Product Lesinurad

24 Apr 2012

AstraZeneca is acquiring San Diego-based Ardea for $32 per share.

Read more 
University-industry Partnerships Declined in 2011, ABPI Survey Finds

University-industry Partnerships Declined in 2011, ABPI Survey Finds

23 Apr 2012

An ABPI report has highlighted the importance of partnerships between universities and pharmaceutical companies and called for greater collaboration to maintain the UK's leadership in medical research.

Read more 
XTL Biopharmaceuticals Reveals Plans to Acquire Drug Development Company

XTL Biopharmaceuticals Reveals Plans to Acquire Drug Development Company

18 Apr 2012

XTL Biopharmaceuticals, a public company traded on the Tel Aviv Stock Exchange, has announced that it has signed a non-binding letter of intent to acquire a drug development company.

Read more 
Express Scripts Solution to Address Medication Non-adherence

Express Scripts Solution to Address Medication Non-adherence

18 Apr 2012

An innovative new solution could help to tackle the major problem of medication non-adherence.

Read more 
Takeda Announces URL Pharma Acquisition

Takeda Announces URL Pharma Acquisition

18 Apr 2012

Takeda is enhancing its gout treatment portfolio with the acquisition of URL Pharma.

Read more 
GE Healthcare Teams up with Clino to Accelerate Alzheimer's Research

GE Healthcare Teams up with Clino to Accelerate Alzheimer's Research

18 Apr 2012

GE Healthcare and Clino Ltd have announced a joint research project with a view to developing new diagnostic solutions for Alzheimer's disease.

Read more 
AMRI Announces Deal with Biota

AMRI Announces Deal with Biota

18 Apr 2012

AMRI’s role will initially involve the development and manufacture of the active pharmaceutical ingredient for use in clinical trials.

Read more 
Amgen to Acquire KAI Pharmaceuticals in $315M Deal

Amgen to Acquire KAI Pharmaceuticals in $315M Deal

17 Apr 2012

KAI Pharmaceuticals is to become a wholly owned subsidiary of Amgen.

Read more 
Humira Receives EU Approval for Ulcerative Colitis

Humira Receives EU Approval for Ulcerative Colitis

16 Apr 2012

Abbot's biologic therapy Humira has now received EU approval for the treatment of adult patients with ulcerative colitis.

Read more 
Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

Shire Announces Top-line Results of Prevent2 Phase-III Trial of MMX Mesalamine

5 Apr 2012

Shire has revealed that it does not plan to pursue a regulatory filing for MMX mesalamine in patients with a history of diverticulitis, after the drug failed to meet the primary endpoint in a recent phase-III study.

Read more 
Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

Merck Announces Publication of Phase-III Data for Shingles Vaccine Zostavax

5 Apr 2012

Efficacy and safety data that supported the US FDA's expanded indication for Zostavax in 2011 have been published in Clinical Infectious Diseases.

Read more 
Catalent & BASF Form Bioavailability Alliance

Catalent & BASF Form Bioavailability Alliance

5 Apr 2012

The companies will combine their expertise to provide a range of services to address pipeline challenges with BCS Class II and IV poorly bioavailable compounds.

Read more